Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency - A randomized double-blind trial

Author: Roifman C.M.   Schroeder H.   Berger M.   Sorensen R.   Ballow M.   Buckley R.H.   Gewurz A.   Korenblat P.   Sussman G.   Lemm G.   the IGIV-C in PID Study Group  

Publisher: Elsevier

ISSN: 1567-5769

Source: International Immunopharmacology, Vol.3, Iss.9, 2003-09, pp. : 1325-1333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content